We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

July 1, 2014

American Sales Company, LLC v. Pfizer, Inc. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. April 19, 2018

    Pfizer Gets Final Nod On $94M Celebrex Antitrust Settlement

    A Virginia federal judge signed off Wednesday on Pfizer’s $94 million settlement, including nearly $31 million in legal fees, with drug buyers who said the pharmaceutical giant extended its monopoly over the anti-inflammatory Celebrex by illegally blocking generic competition.

5 other articles on this case. View all »

Parties

To view the parties, register now.